Cytovant Sciences
Industry
- Pharmaceuticals
- Vaccines
- Biotechnology
- Gene Therapy, Cell Therapy
See more in Biomedtracker
Latest on Cytovant Sciences
Scrip
• By Mandy Jackson
Roivant Sciences Ltd. and Pfizer Inc. officially launched Priovant Therapeutics on 28 June to develop Pfizer’s TYK2/JAK1 inhibitor brepocitinib, but the companies had been working together since
Scrip
• By Deanna Kamienski
While start-up company financings increased from nearly $2.2bn in the third quarter to $3bn in the fourth quarter, mergers and acquisitions involving young biopharmaceutical companies declined from a
Scrip
• By Ian Haydock
Following their early September surprise announcement of a broad alliance, Sumitomo Dainippon Pharma Co. Ltd. (SDP) and Roivant Sciences Inc. have now finalized and fleshed out their $3bn deal und